Array comparative genomic hybridization analysis of olfactory neuroblastoma

Modern Pathology

Volumn 21, Issue 6, 2008, Pages 770-778

  Guled, Mohamed ^a   Myllykangas, Samuel ^a   Frierson Jr , Henry F ^b   Mills, Stacey E ^b   Knuutila, Sakari ^a,d   Stelow, Edward B ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Array CGH; Cytogenetics; Esthesioneuroblastoma; Olfactory neuroblastoma

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CHROMOSOME 13Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 9P; CHROMOSOME XP; CHROMOSOME XQ; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ESTHESIONEUROBLASTOMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADULT; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 44349185433     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.57     Document Type: Article

References (39)

1. Barnes L, (ed) Pathology and Genetics of Head and Neck Tumours. International Agency for Research on Cancer (IARC), Lyon, France, 2005, pp 430.
2. Morita A, Ebersold MJ, Olsen KD, et al. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706-714, discussion 714-715.
3. Holland H, Koschny R, Krupp W, et al. Comprehensive cytogenetic characterization of an esthesioneuroblastoma. Cancer Genet Cytogenet 2007;173:89-96.
4. Bockmuhl U, You X, Pacyna-Gengelbach M, et al. CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol 2004;14:158-163.
5. Riazimand SH, Brieger J, Jacob R, et al. Analysis of cytogenetic aberrations in esthesioneuroblastomas by comparative genomic hybridization. Cancer Genet Cytogenet 2002;136:53-57.
6. Szymas J, Wolf G, Kowalczyk D, et al. Olfactory neuroblastoma: detection of genomic imbalances by comparative genomic hybridization. Acta Neurochir (Wien) 1997;139:839-844.
7. Mills SE, Frierson Jr HF. Olfactory neuroblastoma. A clinicopathologic study of 21 cases. Am J Surg Pathol 1985;9:317-327.
8. Lingjaerde OC, Baumbusch LO, Liestol K, et al. CGH-explorer: a program for analysis of array-CGH data. Bioinformatics 2005;21:821-822.
9. Davila M, Frost AR, Grizzle WE, et al. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 2003;278:36868-36875.
10. Kasamatsu A, Endo Y, Uzawa K, et al. Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses. Int J Biochem Cell Biol 2005;37:1869-1880.
11. Bockmuhl U, Schluns K, Schmidt S, et al. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2002;33:29-35.
12. Stumpf E, Aalto Y, Hoog A, et al. Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer 2000;29:83-87.
13. Zhang Z, Schittenhelm J, Guo K, et al. Upregulation of frizzled 9 in astrocytomas. Neuropathol Appl Neurobiol 2006;32:615-624.
14. Kirikoshi H, Sekihara H, Katoh M. Expression profiles of 10 members of frizzled gene family in human gastric cancer. Int J Oncol 2001;19:767-771.
15. Quinlan KG, Verger A, Yaswen P, et al. Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad. Biochim Biophys Acta 2007;1775:333-340.
16. Schmandt RE, Bennett M, Clifford S, et al. The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary. Cancer Biol Ther 2006;5:1136-1141.
17. Beder LB, Gunduz M, Ouchida M, et al. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 2003;83:99-105.
18. Yamamoto N, Mizoe J, Numasawa H, et al. Allelic loss on chromosomes 2q, 3p and 21q: possibly a poor prognostic factor in oral squamous cell carcinoma. Oral Oncol 2003;39:796-805.
19. Cengiz B, Gunduz M, Nagatsuka H, et al. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer. Oral Oncol 2007;43:241-247.
20. Piao Z, Lee KS, Kim H, et al. Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis. Genes Chromosomes Cancer 2001;30:113-122.
21. Otsuka T, Kohno T, Mori M, et al. Deletion mapping of chromosome 2 in human lung carcinoma. Genes Chromosomes Cancer 1996;16:113-119.
22. Takita J, Yang HW, Chen YY, et al. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 2001;20:4424-4432.
23. Narayan G, Pulido HA, Koul S, et al. Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene 2003;22:3489-3499.
24. Ueda T, Komiya A, Suzuki H, et al. Loss of heterozygosity on chromosome 2 in japanese patients with prostate cancer. Prostate 2005;64:265-271.
25. Takada H, Imoto I, Tsuda H, et al. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Oncogene 2005;24:8051-8060.
26. Barghorn A, Speel EJ, Farspour B, et al. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am J Pathol 2001;158:1903-1911.
27. Kim JH, Dhanasekaran SM, Mehra R, et al. Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 2007;67:8229-8239.
28. Theile M, Seitz S, Arnold W, et al. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 1996;13:677-685.
29. Nakamura M, Kishi M, Sakaki T, et al. Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. Cancer Res 2003;63:737-741.
30. Saramaki OR, Porkka KP, Vessella RL, et al. Genetic aberrations in prostate cancer by microarray analysis. Int J Cancer 2006;119:1322-1329.
31. Kamradt J, Jung V, Wahrheit K, et al. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH. PLoS ONE 2007;2:e769.
32. 32 Abba MC, Fabris VT, Hu Y, et al. Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. Cancer Res 2007;67:4104-4112.
33. Hodgson JG, Chin K, Collins C, et al. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 2003;78:337-345.
34. Wilting SM, Snijders PJ, Meijer GA, et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006;209:220-230.
35. Loukopoulos P, Shibata T, Katoh H, et al. Genomewide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci 2007;98:392-400.
36. Calin GA, Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006;25:6202-6210.
37. Lillington DM, Kingston JE, Coen PG, et al. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer 2003;36:121-128.
38. Lips EH, de Graaf EJ, Tollenaar RA, et al. Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomas. J Pathol 2007;212:269-277.
39. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002;123:1109-1119.